A5065066804- Trypanosoma species research and implications
- Research on Leishmaniasis Studies
- Insect symbiosis and bacterial influences
- Parasitic Diseases Research and Treatment
- Parasites and Host Interactions
Fundación para el Desarrollo de la Ecología
2020-2024
BackgroundVertical transmission of Trypanosoma cruzi represents approximately 20% new Chagas disease cases. Early detection and treatment for women childbearing age newborns is a public health priority, but the lack simple reliable diagnostic test remains major barrier. We aimed to evaluate performance point-of-care loop-mediated isothermal amplification (LAMP) assay T cruzi.MethodsIn this proof-of-concept study, we coupled low-cost 3D printer repurposed sample preparation (PrintrLab) Eiken...
Background Tegumentary leishmaniasis (TL) is a parasitic disease that can present cutaneous or mucocutaneous clinical form (CL and MCL, respectively). The caused by different Leishmania species transmitted phlebotomine sand flies. Bolivia has one of the highest incidences in South America diagnosis done parasitological techniques. Our aim was to describe immunological characteristics CL MCL patients attending reference center Cochabamba, Bolivia, order gain updated epidemiological...
Background Chagas disease, caused by the parasite Trypanosoma cruzi , is a neglected infectious disease that exerts highest public health burden in Americas. There are two anti-parasitic drugs approved for its treatment–benznidazole and nifurtimox—but absence of biomarkers to early assess treatment efficacy hinders patients´ follow-up. Methodology/Principal findings We conducted longitudinal, observational study among cohort 106 chronically T . cruzi- infected patients Cochabamba (Bolivia)...